The prevalence of post-COVID-19 condition (PCC) was 8.4% among US adults in 2023, according to a research letter.

An initiative to improve care and standardize identification, assessment, referrals, and treatment for patients with HCM has been launched by the AHA.

Among the general US population, simple and affordable non-invasive liver fibrosis scoring systems may be able to identify individuals at risk for HF.

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability.

In this diverse cohort study of 1500 children, the trajectory of cardiovascular health scores began to decline at around age 10, associated with health behaviors rather than health factors. Behavioral ...

Vasomotor symptom frequency was associated with an increased risk for type 2 diabetes among female individuals going through menopause.